Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Getting into the weed—the genetics of cannabis use in modern America
    Published on 2025-12-01
    4 days ago
  • The hippocampus as a central hub in ketamine’s antidepressant action: from molecules to circuit rewiring
    Published on 2025-11-25
    1 week ago
  • Orbitofrontal BDNF puts the brakes on alcohol intake and relapse
    Published on 2025-11-24
    2 weeks ago
  • The impact of collider bias on genetic prediction in psychotic disorders
    Published on 2025-11-20
    2 weeks ago
  • Reliable variability in subjective responses to parenteral hydromorphone administration: empirical confirmation of an opioid non-responder phenotype
    Published on 2025-11-17
    3 weeks ago
  • Altered amygdala and striatal responsivity and prediction error encoding of temporal reward dynamics in post-trauma psychopathology
    Published on 2025-11-16
    3 weeks ago
  • IN MEMORIAM: Nolan R. Williams, MD
    Published on 2025-11-14
    3 weeks ago
1 2 3 … 143 Next »
Journal of Psychopharmacology
  • Ketamine/esketamine pharmacotherapy for treatment of anxiety disorders and anxiety symptoms in depression: Systematic review
    Published on 2025-12-05
    23 hours ago
  • Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations
    Published on 2025-12-04
    2 days ago
  • The endocannabinoid system as a therapeutic target in prodromal psychosis: From molecular mechanisms to clinical applications
    Published on 2025-12-02
    4 days ago
  • The role of psychopharmacology and cognitive neuroscience in understanding the brain in the treatment of psychiatric disorders and neurological diseases for the benefit of society
    Published on 2025-12-01
    5 days ago
  • “Too small to succeed?” Rethinking efficacy claims in a solriamfetol trial for ME/CFS
    Published on 2025-12-01
    5 days ago
  • A Bayesian network meta-analysis of randomized controlled trials comparing the efficacy and safety of cholinergic modulators in schizophrenia
    Published on 2025-12-01
    5 days ago
  • Psychedelic research – Going global
    Published on 2025-12-01
    5 days ago
1 2 3 … 134 Next »
European Neuropsychopharmacology
  • The effect of switching antipsychotics to aripiprazole versus paliperidone on weight/cardiometabolic parameters: 18-month follow-up findings from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)
    Published on 2025-12-03
    3 days ago
  • Psychedelics: The pathway to implementation in the European healthcare systems
    Published on 2025-12-03
    3 days ago
  • Exploring clozapine dose adjustment strategy in acute-phase reaction of inflammation based on free drug concentrations and Kpuu
    Published on 2025-11-27
    1 week ago
  • Default mode network integrity across neuropsychiatric disorders and its relation to social dysfunction: A normative modelling approach
    Published on 2025-11-26
    1 week ago
  • Corrigendum to “Does bipolar disorder accelerate cellular aging? A systematic review and meta-analysis of telomere length” [European Neuropsychopharmacology; 2025;99:21-30]
    Published on 2025-11-26
    1 week ago
  • Editorial Board
    Published on 2025-11-25
    1 week ago
  • Three shades of gloom: investigating the genetic background of current depressive symptoms associated with different severity of current stress exposure in a general population
    Published on 2025-11-24
    2 weeks ago
1 2 3 … 153 Next »

   Pharma Pub